Search by Drug Name or NDC
NDC 50991-0788-90 Alahist PE 2; 7.5 mg/1; mg/1 Details
Alahist PE 2; 7.5 mg/1; mg/1
Alahist PE is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Poly Pharmaceuticals, Inc.. The primary component is DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Brompheniramine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, hay fever, and the common cold. Brompheniramine helps control symptoms, but does not treat the cause of the symptoms or speed recovery. Brompheniramine should not be used to cause sleepiness in children. Brompheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 50991-0788-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Brompheniramine
Product Information
| NDC | 50991-0788 |
|---|---|
| Product ID | 50991-788_f4bf7f15-6579-71c4-e053-2a95a90aeb27 |
| Associated GPIs | 43993002500318 |
| GCN Sequence Number | 081496 |
| GCN Sequence Number Description | dexbrompheniramin/phenylephrin TABLET 2MG-7.5 MG ORAL |
| HIC3 | Z2N |
| HIC3 Description | 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION |
| GCN | 48628 |
| HICL Sequence Number | 036892 |
| HICL Sequence Number Description | DEXBROMPHENIRAMINE MALEATE/PHENYLEPHRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Alahist PE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dexbrompheniramine Maleate, Phenylephrine Hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2; 7.5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Poly Pharmaceuticals, Inc. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50991-0788-90 (50991078890)
| NDC Package Code | 50991-788-90 |
|---|---|
| Billing NDC | 50991078890 |
| Package | 90 TABLET in 1 BOTTLE (50991-788-90) |
| Marketing Start Date | 2020-08-24 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.6226 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | ALAHIST PE 2-7.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis